newsfilter
← Latest News
GlobeNewswire·

NGM Bio Outlines Corporate Strategy and Provides Guidance on Key Priorities

NGM Bio's three-pronged corporate strategy includes the following components: Focus internal clinical development efforts on solid tumor oncology portfolioGenerate next-generation biologics through prolific in-house